Ilaris 150 mg/mL injection Images
Generic Name: canakinumab
This medication has been identified as Ilaris 150 mg/mL injection and is used for Cryopyrin-Associated Periodic Syndromes, Familial Cold Autoinflammatory Syndrome, Familial Mediterranean Fever, Gout, Acute, and Hyperimmunoglobulin D Syndrome. It belongs to the drug class interleukin inhibitors and is not a controlled substance.
Images of medication
Ilaris
- Generic Name
- canakinumab
- Strength
- 150 mg/mL injection
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-0734
See also:
More about Ilaris (canakinumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.